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PPeripheral Arterial Disease
The Ankle-Brachial Index and
Incident Cardiovascular Events in the
MESA (Multi-Ethnic Study of Atherosclerosis)
Michael H. Criqui, MD, MPH,* Robyn L. McClelland, PHD,† Mary M. McDermott, MD,‡
Matthew A. Allison, MD, MPH,* Roger S. Blumenthal, MD,§ Victor Aboyans, PHD,
Joachim H. Ix, MD, MAS,* Gregory L. Burke, MD, MS,¶ Kaing Liu, PHD,‡ Steven Shea, MD, MS#
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Winston-Salem, North Carolina; and New York, New York
Objectives The purpose of this study was to examine the association of both a low and a high ankle-brachial index (ABI)
with incident cardiovascular events in a multiethnic cohort.
Background Abnormal ABIs, both low and high, are associated with elevated cardiovascular disease (CVD) risk. However, it is
unknown whether this association is consistent across different ethnic groups, and whether it is independent of
both newer biomarkers and other measures of subclinical atherosclerotic CVD.
Methods A total of 6,647 non-Hispanic white, African-American, Hispanic, and Chinese men and women age 45 to 84
years from free-living populations in 6 U.S. field centers and free of clinical CVD at baseline had extensive mea-
sures of traditional and newer biomarker risk factors, and measures of subclinical CVD, including the ABI. Inci-
dent CVD, defined as coronary disease, stroke, or other atherosclerotic CVD death, was determined over a mean
follow-up of 5.3 years.
Results Both a low (1.00) and a high (1.40) ABI were associated with incident CVD events. Sex- and ethnic-specific
analyses showed consistent results. Hazard ratios were 1.77 (p  0.001) for a low and 1.85 (p  0.050) for a
high ABI after adjustment for both traditional and newer biomarker CVD risk factors, and the ABI significantly
improved risk discrimination. Further adjustment for coronary artery calcium score, common and internal carotid
intimal medial thickness, and major electrocardiographic abnormalities only modestly attenuated these hazard
ratios.
Conclusions In this study, both a low and a high ABI were associated with elevated CVD risk in persons free of known CVD,
independent of standard and novel risk factors, and independent of other measures of subclinical CVD. Further
research should address the cost effectiveness of measuring the ABI in targeted population groups. (J Am Coll
Cardiol 2010;56:1506–12) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.04.060v
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Feripheral artery disease (PAD) is prevalent worldwide and
n all ethnic groups in the U.S. (1). It can be accurately
iagnosed with the ankle-brachial index (ABI), and low
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010, accepted April 14, 2010.alues of the ABI are strongly predictive of incident cardio-
ascular disease (CVD) events and CVD, as well as total
ortality (2–5). These associations hold true in both sexes and
re independent of traditional CVD risk factors and extant
VD at baseline (2,4,5). Recently, a meta-analysis of 16
eneral population studies worldwide demonstrated that as
pposed to the conventional definition of a normal ABI as
0.90, the true normal range of the ABI appears to be 1.00 to
.40, with both higher and lower values associated with
ncreased risk of CVD events (5). Second, the risk associated
ith an abnormal ABI contributed incremental information to
he Framingham Risk Score (FRS), and the risk of a CVD
vent with an abnormal ABI was present at every level of the
RS. Third, the ABI increased the area under the receiver-
perating characteristic (ROC) curve beyond the FRS predic-
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October 26, 2010:1506–12 Ankle-Brachial Index and Cardiovascular Eventsion. However, the questions of whether the ABI provides
ncremental risk information beyond newer biomarkers, or
eyond other measures of subclinical CVD, or in ethnic groups
ther than non-Hispanic white (NHW), have not previ-
usly been addressed.
In the MESA (Multi-Ethnic Study of Atherosclerosis),
ultiple newer biomarkers were measured as well as the
tandard CVD risk factors, and in addition to the ABI,
dditional tests of subclinical cardiovascular disease were
erformed (6). Participants had measurements of coronary
rtery calcium (CAC) by computed tomography (CT),
arotid intimal medial thickness (CIMT) by ultrasound, and
ajor electrocardiographic (ECG) abnormalities. CAC in
ESA showed strong predictive power for incident CVD
vents (7), and CIMT was also significantly associated with
VD events, though less so than CAC (8). Here, we
xplored the ethnic-specific associations of the ABI with
VD events, and whether the predictive power of the ABI
as independent of newer biomarkers as well as standard
VD risk factors, and independent of other subclinical
easures in MESA (i.e., CAC, CIMT, and major ECG
bnormalities).
ethods
articipants. Details of the study design and protocol have
een published (6). In brief, between July 2000 and August
002, 6,814 NHW, African-American, Hispanic, or Chi-
ese men and women 45 to 84 years of age and free of
linically apparent CVD were recruited from 6 communities
nd participated in the baseline examination.
ata collection. At the baseline examination, standardized
uestionnaires were used to obtain demographic informa-
ion and level of education, annual household income,
moking history, and medication usage for high blood
ressure, high cholesterol, or diabetes. Cigarette smoking
as calculated in pack-years and also defined as current,
ormer, or never. Body mass index (BMI) was calculated as
eight in kilograms divided by height in meters squared.
ystolic and diastolic resting blood pressures were measured
n seated participants.
aboratory. Total and high-density lipoprotein (HDL)
holesterol, triglycerides, and glucose levels were measured
rom blood samples obtained after a 12-h fast. Low-density
ipoprotein cholesterol was calculated by the Friedewald
quation. Diabetes was defined as fasting glucose 126
g/dl or use of hypoglycemic medication. Using fasting
lood samples from the baseline visit, the following analytes
ere selected based on their association with the ABI in
rior analyses: high-sensitivity plasma C-reactive protein
CRP), fibrinogen, interleukin (IL)-6, D-dimer, estimated
lomerular filtration rate (eGFR), and homocysteine (9).
he laboratory methodology for these variables has been
ublished (10).
BI protocol. Systolic blood pressure measurements in the
ilateral brachial, dorsalis pedis, and posterior tibial arteries here obtained in the supine po-
ition using a hand-held Doppler
nstrument with a 5-mHz probe.
o avoid potential bias from sub-
lavian stenosis, the higher of the
rachial artery pressures was used
s the denominator (11). For
ach lower extremity, the ABI
umerator used was the highest
ressure (dorsalis pedis or poste-
ior tibial) from that leg. The leg
uff was inflated to a maximum
f 300 mm Hg, and if a pulse was
till detected at this level, the
BI was classified as “incompress-
ble.” A subset of 384 MESA par-
icipants had replicate ABI mea-
urements that showed excellent
eproducibility. Participants were
lassified into 1 of 3 ABI catego-
ies: “normal” when both legs had
alues 1.00  ABI 1.4; “low”
hen a least 1 leg had a value
1.00; and “high” when at least
leg was 1.40 or incompress-
ble and the other leg was high/
ncompressible or normal.
ubclinical CVD assessment.
canning centers assessed CAC
y CT using either a cardiac-
ated electron-beam CT scanner
r a multidetector CT system (11,12). The mean phantom-
djusted Agatston score was used in all analyses (13).
rained technicians performed B-mode ultrasonography of
he right and left near and far walls of the internal carotid
nd common carotid arteries (13). Three 12-lead recordings
ere obtained using a Marquette MAC-PC instrument
Marquette Electronics, Milwaukee, Wisconsin) and read
sing Novacode criteria (14).
VD follow-up. Follow-up went from the baseline ex-
mination until the first CVD event, loss to follow-up,
eath, or the sixth follow-up call, for a follow-up median
f 4.8 and a mean of 5.3 years (maximum, 6.5 years). For
his report, we defined incident CVD as coronary heart
isease (CHD) (definite and probable MI, definite CHD
eath, resuscitated cardiac arrest, and definite angina),
troke (fatal or nonfatal), or other atherosclerotic CVD
eath. Details of CVD event ascertainment have been
ublished (7).
tatistical analysis. From the 6,814 MESA participants,
e excluded 167 with missing ABI values, leaving 6,647
articipants for analysis. Age-, sex-, and ethnicity-adjusted
eans and percentages of potential risk factors by ABI
roup were computed using either linear or logistic regres-
ion models. A natural log (ln) transformation was used for
Abbreviations
and Acronyms
ABI  ankle-brachial index
BMI  body mass index
CAC  coronary artery
calcium
CHD  coronary heart
disease
CIMT  carotid intimal
medial thickness
CRP  C-reactive protein
CT  computed
tomography
CVD  cardiovascular
disease
ECG  electrocardiographic
eGFR  estimated
glomerular filtration rate
FRS  Framingham Risk
Score
HDL  high-density
lipoprotein
HR  hazard ratio
IL  interleukin
NHW  non-Hispanic white
PAD  peripheral artery
disease
ROC  receiver operating
characteristicighly skewed variables. For CVD outcome analyses, we
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Ankle-Brachial Index and Cardiovascular Events October 26, 2010:1506–12tilized the 3 levels of ABI (normal, low, high) for categor-
cal analyses, and also employed ABI as a continuous
ariable, excluding participants with an ABI 1.40. Cox
roportional hazard regression was used to estimate hazard
atios (HRs). We performed tests for nonproportional
azards across ABI categories using Schoenfeld residuals
15); all results were nonsignificant. Additionally, interac-
ions between time and ABI category were also nonsignif-
cant. In order to examine the independence of the ABI
ith increasing levels of adjustment, 4 separate Cox models
ere run. Model 1 was adjusted for age, sex, and ethnicity.
odel 2 added education, income, and the traditional CVD
isk factors noted in Table 1, that is, smoking (never/
ormer/current and pack-years), BMI, diabetes, systolic and
iastolic blood pressure, antihypertensive medications, total
holesterol to HDL ratio, log triglycerides, and lipid-
owering medications. Model 3 added the newer biomark-
rs: CRP, IL-6, fibrinogen, D-dimer, eGFR, and homocys-
eine. Model 4 added CAC (none, 1 to 100, and 100
gatston units), both common and internal CIMT values as
ontinuous variables, and major ECG abnormalities, in
ssociation of Age, Sex, and Race/Ethnicity With ABI Category, aex-, and Race/Ethnicity-Adjusted Distribu ions of Risk Factors byTable 1 Associat on of Age, Sex, and Race/Ethnicity With ABISex-, and Race/Ethnicity-Adjusted Distributions of Ris
ABI Cate
Normal 1.0 < ABI <1.4
(n  5,731)
Low ABI <1.0
(n  806)
Age, yrs 61.3 10.0 66.3 10.3
Male, mean (n) 49.0 (2,808) 32.0 (258)
Female, mean (n) 51.0 (2,923) 68.0 (548)
Race/ethnicity
White, mean (n) 38.3 (2,195) 36.5 (294)
Chinese, mean (n) 12.7 (728) 8.6 (69)
African American, mean (n) 25.8 (1,479) 41.3 (333)
Hispanic, mean (n) 23.2 (1,329) 13.7 (110)
Age-, Sex-, and Race/Ethnicity-A
Current smoking, % 10 20
Pack-years of smoking, % 10.6 17.6
High school graduate, % 88 84
Household income $25,000, % 27 33
Body mass index, kg/m2 28.3 28.1
Diabetes, % 10 14
Systolic BP, mm Hg 126 132
Diastolic BP, mm Hg 72 72
Antihypertensive medications, % 35 41
Hypertension, % 43 54
TC/HDL ratio 4.06 4.27
Log triglycerides, log mg/dl 4.72 4.78
Lipid-lowering medications, % 15 19
Dyslipidemia, % 32 45
ln CRP, log mg/l 0.62 0.80
ln IL-6, log pg/ml 0.19 0.35
Fibrinogen, mg/dl 345 357
ln D-dimer, log g/ml 1.53 1.41
eGFR, ml/min/1.73 m2 81.4 80.3
ln homocysteine, log mol/l 2.17 2.21BI  ankle-brachial index; BP  blood pressure; CRP  C-reactive protein; eGFR  estimated glomerulrder to provide maximum adjustment for any confounding
y other subclinical CVD. Model 3 was employed in
valuating the association of ABI category with coronary
isease and stroke events separately. Separate models were
lso run within ethnic groups adjusted for age and sex.
aplan-Meier event curves were drawn for the 3 ABI
ategories, and CVD event rates per 1,000 person-years at
isk were calculated for the ABI categories stratified by
AC levels (0, 1 to 100, and 100 Agatston units). The
ncremental value of ABI to the prediction of events in
ESA was evaluated both by the improvement in the area
nder the ROC curve and the “integrated discrimination
mprovement” (IDI) (16). All analyses were performed
sing STATA version 10.1 (StataCorp, College Station,
exas) statistical software.
esults
able 1 shows first the distribution of age, sex, and ethnicity
cross the low, normal, and high ABI groups. Both low and
igh ABI groups were somewhat older than the normal
e-,Categorygory, and Age-,
tors by ABI Category
p Value
High ABI >1.4 or Incompressible
(n  110) Low vs. Normal High vs. Normal
64.9 10.3 0.001 0.001
77.3 (85) 0.001 0.001
22.7 (25) 0.001 0.001
48.2 (53) 0.32 0.03
2.7 (3) 0.001 0.002
25.5 (28) 0.001 0.93
23.6 (26) 0.001 0.91
d Means and Percentages
7 0.001 0.25
9.9 0.001 0.95
86 0.001 0.44
29 0.001 0.60
30.1 0.20 0.001
23 0.001 0.001
124 0.001 0.46
71 0.40 0.15
37 0.001 0.68
40 0.001 0.67
3.86 0.001 0.09
4.74 0.002 0.66
14 0.001 0.78
27 0.001 0.18
0.84 0.001 0.04
0.32 0.001 0.04
356 0.001 0.12
1.41 0.001 0.16
81.5 0.076 0.95
2.25 0.001 0.004nd AgABICate
k Fac
gory
djustear filtration rate; HDL  high-density lipoprotein; IL  interleukin; TC  total cholesterol.
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October 26, 2010:1506–12 Ankle-Brachial Index and Cardiovascular Eventsroup, and women were more common in the low and men
ore common in the high ABI groups. Compared to
HWs, African Americans were more likely to be in the
ow ABI group, whereas Hispanics and Chinese were less
ikely. Chinese were also less likely to be in the high ABI
roup. Because of these differences, the baseline risk factor
evels in the remainder of Table 1 were adjusted for age, sex,
nd ethnicity.
Education and income levels were lower in the low ABI
roup. With the exception of BMI, traditional CVD risk
actors were uniformly significantly higher in the low ABI
roup, whereas only BMI and diabetes were higher in the
igh ABI group. Among the 6 novel biomarkers, hs-CRP,
l-6, and homocysteine were all significantly higher in both
he low and high ABI groups. Fibrinogen and D-dimer were
igher, and eGFR borderline lower, in the low ABI group.
There were 317 first CVD events during follow-up, 226
HD events, 89 strokes (including 7 who also had CHD
vents), and 9 “other” atherosclerotic CVD deaths. CVD
vent rates per 1,000 person-years in men for NHW,
frican Americans, Hispanics, and Chinese were 14.9,
4.5, 16.1, and 10.2, respectively, and for women 8.4, 7.4,
.4, and 3.7, respectively. Figure 1 shows Kaplan-Meier
vent curves illustrating the similarly increased hazard of
VD events for both a low and a high ABI over time
ompared with a normal ABI. Table 2 shows the results of
he proportional hazards analysis. Adjusted for age, sex, and
thnicity (model 1), a low ABI was associated with a HR of
.30 (p  0.001) for CVD events. Adjustment for tradi-
Figure 1 Kaplan-Meier Event Curves for Incident CVD by ABI C
Kaplan-Meier event curves for incident cardiovascular disease (CVD) by ankle-brac
over an average of 5.3 years of follow-up in the MESA (Multi-Ethnic Study of Atheroional CVD risk factors in addition (model 2) attenuated the
R to 1.78 (p  0.001). Further adjustment (model 3) for
ewer biomarkers produced no change (HR: 1.77, p 
.001). Finally, adjustment for multiple subclinical CVD
easures, CAC, both common and internal CIMT, and
ajor ECG abnormalities attenuated the HR somewhat to
.46, but the association remained significant (p  0.021).
A high ABI was also associated with an increased risk,
nd after multiple adjustment (model 3), the HR was 1.85,
 0.050, which was a similar effect size as for the low
BI. Additional adjustment for CAC, common and inter-
al CIMT, and major ECG abnormalities attenuated the
R somewhat to 1.69, p 0.099. Tests of the these models
or sex–ABI interactions were not significant. After model 2
djustment for the categorical ABI analysis, the area under
he ROC curve was 0.78 without and 0.79 with the ABI,
 0.022 for the difference, and the IDI index showed that
he ABI contributed significantly (p  0.003) to improving
lassification of events and non-events. Table 2 shows that
esults were similar for analyses with ABI as a continuous
ariable (excluding ABIs 1.40), and a generalized additive
odel fit to examine potential nonlinearity indicated that
fter covariate adjustment there was little deviation from a
inear inverse relationship across the ABI values.
Figure 2 illustrates the risk of CVD events by ABI group
ithin strata of CAC. In those without any CAC, incidence
ates were quite low irrespective of ABI group. In the groups
ith nonzero CAC, ABI showed a U-shaped association
ithin CAC groups. As a continuous variable, ABI was
ries
ex (ABI) categories
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Ankle-Brachial Index and Cardiovascular Events October 26, 2010:1506–12nversely and significantly related to the CVD event rate
mong those with any CAC (data not shown). Models
imited to “hard” CVD events (i.e., excluding angina and
other” CVD deaths) showed similar results except for
educed statistical power (data not shown).
Additional models evaluated the association of the ABI
efined continuously (excluding ABIs 1.40) within ethnic
roups, adjusted for age and sex. The HRs were quite
imilar: 0.74 for NHWs, 0.80 for Hispanics, 0.83 for
hinese, and 0.87 for African Americans. Although power
as insufficient to analyze the ABI categorically within
thnic groups, an additional Cox model was run including
n interaction term for ABI group  ethnicity. The p value
or the interaction term was 0.71, confirming the similar
ffect size for ABI within ethnic groups.
isk of Incident Cardiovascular Events by ABI LevelTable 2 Risk of Incident Cardiovascular Events by ABI Level
ABI Categor
Normal (1.0 < ABI <1.4)
(n  5,731)
Low (<1.00)
(n  806)
Events 226 80
Rate per 1,000 PY 8.7 23.1
Model 1 1.00 2.30 (1.76–3.00)
Model 2 1.00 1.78 (1.32–2.39)
Model 3 1.00 1.77 (1.31–2.40)
Model 4 1.00 1.46 (1.06–2.00)
ee Methods for variables in Models 1, 2, and 3. Event rate is per 1,000 person-years (PY) at risk.
xpressed per 0.10 increment.
ABI  ankle-brachial index; CI  confidence interval; HR  hazards ratio.
Figure 2 Unadjusted Rates of Incident CVD per 1,000
Person-Years at Risk by Categories of ABI and CAC
Rates of incident CVD per 1,000 person-years at risk by categories of ABI and
coronary artery calcium (CAC) over an average of 5.3 years of follow-up in the
MESA. CI  confidence interval; other abbreviations as in Figure 1.tModels were also run for CHD and stroke events
eparately, using model 2 adjustments. For CHD end
oints, the low and high ABIs again showed similar hazard
atios, 1.87 (p 0.001) and 2.15 (p 0.029). However, the
esults appeared to differ for stroke, where high ABI was
ssociated with a HR of 2.69, p  0.06, whereas low ABI
howed a weaker association, HR: 1.56, p  0.10.
iscussion
sing updated and more accurate definitions of a normal,
ow and high ABI (5), this study confirmed the independent
ssociation of both a low and high ABI with future CVD
vents in an ethnically diverse community dwelling popu-
ation of men and women without symptomatic CVD at
aseline. Addition of the ABI to risk factors resulted in
inor but significant improvement in the area under the
OC curve. However, this statistic has been criticized as
ot providing the full potential discriminating value of a risk
arker, since a marker producing only modest change in the
OC curve can nonetheless substantially improve risk
lassification, as was the case here (17). Several studies have
eported higher risks than those shown here, but such
tudies included persons with known CVD at baseline, and
ere thus enriched with higher-risk persons with lower
BIs on average than for this primary prevention cohort.
his study demonstrates that in a healthy population with
areful exclusion for any known CVD at baseline that both
low and a high ABI predict incident CVD events.
Analysis of CHD and stroke events separately demon-
trated that a high ABI was more strongly associated with
troke (HR: 2.69) than a low ABI (HR: 1.56), and despite
he small numbers, the p value for the high ABI was
orderline statistically significant (p  0.06). This is un-
ikely to be a chance finding, since it has been reported
reviously (18,19). A high ABI is thought to represent stiff
rterial walls, potentially including medial arterial calcifica-
ion. That is, the value for the ankle artery is not an accurate
easure of intra-arterial pressure but rather a falsely high
alue due to stiffness in the arterial wall. Thus, whether such
ersons have PAD cannot be determined with the ABI,
Continuous ABI
e
High (>1.4)
(n  110) p Value
Excluding ABI >1.4
(n  6,537) p Value
11 — 306 —
22.6 — 10.4 —
1 1.68 (0.91–3.09) 0.090 0.80 (0.74–0.87) 0.001
1 1.82 (0.98–3.34) 0.058 0.89 (0.82–0.98) 0.012
1 1.85 (1.00–3.43) 0.050 0.86 (0.81–0.97) 0.008
1.69 (0.91–3.14) 0.099 0.94 (0.86–1.03) 0.210
for Models 1 to 4 are hazard ratio (95% confidence interval). Coefficients for continuous ABI arey
p Valu
—
—
0.00
0.00
0.00
0.021
Valueshough one-half or more may have PAD (20,21). Thus,
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October 26, 2010:1506–12 Ankle-Brachial Index and Cardiovascular Eventsany persons in the high ABI group could have the CVD
isk associated with PAD, but may have a separate stroke-
pecific risk as well. The reason for this is unclear, though a
pecific link between arterial stiffening and microvascular
isease in the brain has been suggested (22), and prior
tudies using other measures of vascular stiffness such as
ulse wave velocity have also shown stronger associations
ith stroke than with other CVD events (23).
Although it has been well established that African Amer-
cans have considerably higher, and Hispanics and Asians
lightly lower, prevalence rates of PAD compared with
HWs (9,24,25), previous studies have not explored po-
ential differences in the predictive value of the ABI for
ncident CVD within ethnic groups. The findings here were
imilar for each of the 4 ethnic groups considered separately.
Earlier studies, including the ABI Collaboration meta-
nalysis (5), in general did not adjust for newer biomarkers.
able 1 shows that indeed such newer biomarkers were
ssociated with both a low and a high ABI. However,
djustment for these newer biomarkers resulted in little
hange.
In the MESA, CAC showed high HRs and significant
mprovement in the area under the ROC curve over
raditional CVD risk factors alone (7). Here, the association
f either a low or a high ABI with CVD events was only
odestly attenuated after adjustment for CAC, both com-
on and internal CIMT, and major ECG abnormalities
Table 2). Thus, the predictive value of an abnormal ABI
emained independent of other measures of subclinical
therosclerosis.
The evidence to date suggests that both CIMT (8), and
ere, the ABI have independent predictive power beyond
isk factors and CAC burden. However, it is much easier,
uicker, less expensive, and safer to measure the ABI than
AC or CIMT. The data here are the first, to our
nowledge, to show the risk of a subclinical measure (ABI)
djusted for traditional and novel risk factors, and for
ultiple other subclinical measures, simultaneously.
Considering that fewer than 10% of persons with PAD in
general population have ischemic leg pain (26), this
uggests the potential benefit of identifying such high-risk
ndividuals with targeted ABI screening (27). Although
pecific ABI screening criteria have been endorsed by
ultiple national societies (28), to date a cost-effectiveness
nalysis of such targeted screening has not been published.
tudy strengths and limitations. Strengths of our study
nclude standardized and validated protocols in a large
ultiethnic population, measurement of traditional as well
s novel risk factors, and assessment of subclinical CVD in
population free of clinical CVD at baseline. Our study also
as limitations. The ABI was measured only once at
aseline. However, test/retest reliability is good, with a
ean error of about 9% within and between observers (29),
nd nonsystematic misclassification of the ABI at baseline
ould have been biased toward the null hypothesis. Partic-pants were alerted to low (but not high) ABIs, and thus
1ersons with low ABIs may have differentially received new
r more aggressive cardiovascular therapy. Here again, any
uch bias would be toward the null hypothesis. There were
nly 11 CVD events in the high ABI group, and numbers
ere inadequate to evaluate the ethnic-specific risk of a high
BI, so these results must be interpreted cautiously.
onclusions
n a primary prevention population, both a low ABI,
iagnostic for PAD, and a high ABI, indicative of medial
rterial calcification and possible PAD, were associated with
ncident CVD events. A high ABI was more strongly
ssociated with stroke than was a low ABI. These associa-
ions were largely independent of standard CVD risk
actors, newer biomarkers, CAC, CIMT, and major ECG
bnormalities, and did not vary by ethnic group. Given the
implicity and low cost of measuring the ABI, cost-
ffectiveness analyses for the use of ABI in targeted groups
hould be a research priority.
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